Financial Performance - The company's net profit attributable to shareholders is expected to be between 80 million and 105 million CNY, representing a year-on-year increase of 80.14% to 136.44% compared to 44.41 million CNY in the same period last year[2]. - The net profit after deducting non-recurring gains and losses is projected to be between 54 million and 79 million CNY, indicating a year-on-year growth of 123.53% to 227.02% from 24.16 million CNY last year[2]. - The basic earnings per share is anticipated to be between 0.19 CNY and 0.24 CNY, compared to 0.10 CNY per share in the same period last year[2]. Factors Influencing Performance - The increase in performance is primarily attributed to significant price increases in key raw materials such as palm oil and fatty alcohol, which have driven up product prices and profits[1]. - The company has gradually released new production capacity and continues to promote refined management to achieve cost reduction and efficiency improvement[1]. Forecast and Caution - The performance forecast is based on preliminary calculations by the company's finance department and may differ from the final data disclosed in the 2024 semi-annual report[5]. - The company emphasizes the importance of cautious decision-making and awareness of investment risks for investors[5]. - The earnings forecast period is from January 1, 2024, to June 30, 2024[2]. - The announcement of the performance forecast was made on July 9, 2024[6].

证券代码：002637 证券简称：赞宇科技 公告编号： 2024-034 赞宇科技集团股份有限公司 关于回购股份的进展公告 1、公司未在下列期间回购公司股份： （1）自可能对本公司股票交易价格产生重大影响的重大事项发生之日或者 在决策过程中，至依法披露之日内； （2）中国证监会和深圳证券交易所规定的其他情形。 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 赞宇科技集团股份有限公司（以下简称"公司"）于2023年10月25日召开第六 届董事会第十二次会议，审议通过了《关于回购股份的方案》，同意公司使用自 有资金以集中竞价交易方式回购部分公司已在境内发行的人民币普通股（A股） 股票，用于后期实施股权激励或员工持股计划。本次回购股份的资金总额为不低 于人民币5,000万元（含）且不超过人民币10,000万元（含），回购股份价格不超 过人民币15.40元/股（含），具体回购资金总额以回购结束时实际回购使用的资 金总额为准。本次回购股份的期限自董事会审议通过本次回购股份方案之日起12 个月内。具体内容详见公司在《证券时报》和巨潮资讯网（www.cninfo ...

证券代码：002637 证券简称：赞宇科技 公告编号： 2024-031 赞宇科技集团股份有限公司 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 赞宇科技集团股份有限公司（以下简称"公司"）于2023年10月25日召开第六 届董事会第十二次会议，审议通过了《关于回购股份的方案》，同意公司使用自 有资金以集中竞价交易方式回购部分公司已在境内发行的人民币普通股（A股） 股票，用于后期实施股权激励或员工持股计划。本次回购股份的资金总额为不低 于人民币5,000万元（含）且不超过人民币10,000万元（含），回购股份价格不超 过人民币15.40元/股（含），具体回购资金总额以回购结束时实际回购使用的资 金总额为准。本次回购股份的期限自董事会审议通过本次回购股份方案之日起12 个月内。具体内容详见公司在《证券时报》和巨潮资讯网（www.cninfo.com.cn） 上披露的《关于回购公司股份方案的公告》（公告编号：2023-058）、《关于以 集中竞价交易方式回购公司股份的回购报告书》（公告编号：2023-060）。 根据《上市公司股份回购规则》《深圳证券 ...

上海市锦天城律师事务所 关于赞宇科技集团股份有限公司 2023 年年度股东大会的 法律意见书 锦 天 城 律 师事 务 所 ALLBRIGHT LAW OFFICES 地址：上海市浦东新区银城中路 501 号上海中心大厦 9、11、12 层 邮编:200120 传真: 021-20511999 电话: 021-20511000 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于赞宇科技集团股份有限公司 2023 年年度股东大会的法律意见书 致：赞宇科技集团股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受赞宇科技集团股份有限 公司（以下简称"公司"）委托，就公司召开 2023 年年度股东大会（以下简称 "本次股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称《公 司法》）、《上市公司股东大会规则》等法律、法规和其他规范性文件以及《赞 宇科技集团股份有限公司章程》（以下简称《公司章程》）的有关规定，出具本 法律意见书。 为出具本法律意见书，本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则》等规定，严格履行了法定职 责，遵循了勤勉尽责 ...

证券代码：002637 证券简称：赞宇科技 公告编号：2024-030 赞宇科技集团股份有限公司 2023年年度股东大会决议公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 特别提示： 1、本次股东大会无增加、变更、否决提案的情况； 2、本次股东大会以现场表决与网络投票相结合的方式召开。 一、会议召开和出席情况 1、会议召开情况 （1）现场会议召开时间：2024 年 5 月 16 日（周四）13：30 （2）网络投票时间为：2024 年 5 月 16 日（周四） 其中：通过深圳证券交易所交易系统进行网络投票的具体时间为：2024 年 5 月 16 日 9:15 - 9:25；09:30-11:30， 13:00-15:00；通过深圳证券交易所互联网 投票系统投票的具体时间为：2024 年 5 月 16 日 09:15-15:00 期间的任意时间。 （3）会议召开地点：赞宇科技集团股份有限公司 A1815 大会议室（地址： 杭州市西湖区古墩路 702 号 18 楼）。 （4）会议召开方式：本次股东大会以用现场表决与网络投票相结合的方式 召开。 A ...

证券代码：002637 证券简称：赞宇科技 赞宇科技集团股份有限公司投资者关系活动记录表 编号：2024-003 投资者关系活 特定对象调研 □分析师会议 动类别 □媒体采访 □业绩说明会 □新闻发布会 □ 路演活动 □现场参观 □其他 （ ） 参与单位名称 中泰证券 王佳博，海富通基金 宫衍海，申万宏源 赵文琪， 及人员姓名 华夏基金 韩霄，长盛基金 钱文礼，阳光资管 何欣知，永禾 投资 张文乾，国海证券 李永磊、董伯骏，华泰柏瑞基金 谭 笑，国信证券 杨林、王新航、王梦婷等。 时间 2024年5月7日-10日 地点 上海、北京 上市公司接待 董秘徐强、证券事务代表郑乐东 人员姓名 双方就公司 2023 年度经营情况、未来发展战略规划等 相关问题进行了沟通，相关问答记录如下： 问：请问公司2023年度业绩增长的原因？ 答：2022 年因原材料采购价格大幅波动导致利润下 降。 2023 年公司产品生产所需主要原材料棕榈油、脂肪醇 ...

赞宇科技集团股份有限公司 证券代码：002637 证券简称：赞宇科技 公告编号： 2024-028 一、回购股份的进展情况 截至2024年4月30日，公司通过回购专用证券账户以集中竞价交易方式累计 回购股份数量为7,350,600股，占公司股份总数的比例为1.56%，最高成交价为人 民币10.83元/股，最低成交价为人民币6.94元/股，成交总金额为人民币 65,992,386.04元（不含交易费用）。本次回购符合既定的回购方案和回购报告书 及相关法律法规的规定。 二、其他说明 公司回购股份的时间、数量、价格及集中竞价交易的委托时段符合《深圳证 券交易所上市公司自律监管指引第9号——回购股份》第十七条、第十八条的相 关规定，具体说明如下： 1、公司未在下列期间回购公司股份： （1）自可能对本公司股票交易价格产生重大影响的重大事项发生之日或者 在决策过程中，至依法披露之日内； 关于回购股份的进展公告 本公司及董事会全体人员保证公告内容真实、准确和完整，并对公告中的 虚假记载、误导性陈述或者重大遗漏承担责任。 赞宇科技集团股份有限公司（以下简称"公司"）于2023年10月25日召开第六 届董事会第十二次会议，审议 ...

Investment Rating - The report maintains an "Outperform" rating for the company [6]. Core Views - The company reported a revenue of 9.612 billion yuan in 2023, a year-over-year decrease of 14.45%. However, it achieved a net profit attributable to shareholders of 87.88 million yuan, marking a turnaround from losses in the previous year [6]. - The first quarter of 2024 saw a revenue of approximately 2.441 billion yuan, a year-over-year decline of 11.7%, but a significant increase in net profit attributable to shareholders to about 51.16 million yuan, reflecting a year-over-year growth of 126% [6]. - The company is expected to benefit from the stabilization and recovery of palm oil prices, which will improve product price differentials and profitability [15]. Summary by Sections Financial Performance - In 2023, the company achieved total revenue of 9.612 billion yuan, with a gross profit margin of 6.2% [7]. - The net profit attributable to shareholders for 2023 was 88 million yuan, with an expected increase to 252 million yuan in 2024 [16]. - The company’s operating profit for 2023 was 114 million yuan, with projections of 274 million yuan for 2024 [7][16]. Product Segments - The surfactants business generated revenue of 3.398 billion yuan in 2023, with a gross margin of 5.05% [6]. - The oil chemical segment reported revenue of 5.936 billion yuan, with a gross margin of 6.48% [6]. Future Projections - The company forecasts net profits of approximately 2.52 billion yuan, 3.49 billion yuan, and 4.23 billion yuan for 2024, 2025, and 2026, respectively [6]. - The expected price-to-earnings ratios for these years are approximately 18, 13, and 10 times [6]. Market Context - The report highlights that the company is positioned within the "Other Chemical Products" industry, which has an average PE ratio of 22-23 times for 2024 [6].

Financial Performance - The company's revenue for Q1 2024 was ¥2,440,940,429.16, a decrease of 11.68% compared to ¥2,763,626,225.07 in the same period last year[5] - Net profit attributable to shareholders increased by 126.15% to ¥51,156,608.30 from ¥22,620,537.10 year-on-year[5] - The net profit after deducting non-recurring gains and losses rose by 138.66% to ¥29,804,541.16 compared to ¥12,488,085.34 in the previous year[5] - Basic and diluted earnings per share increased by 140.00% to ¥0.12 from ¥0.05 year-on-year[5] - Net profit for Q1 2024 reached CNY 47,732,864.06, significantly higher than CNY 16,677,486.03 in Q1 2023, representing an increase of 186.5%[20] - The company reported a significant increase in profit attributable to the parent company, reaching CNY 51,156,608.30 in Q1 2024, compared to CNY 22,620,537.10 in Q1 2023, an increase of 126.5%[20] Cash Flow - The net cash flow from operating activities improved by 70.94%, reaching -¥49,026,712.01, compared to -¥168,691,301.53 in the same period last year[5] - The net cash flow from operating activities was -49,026,712.01 CNY, improving from -168,691,301.53 CNY year-over-year[24] - The company incurred a net cash outflow from investing activities of -59,924,570.81 CNY, compared to -213,366,471.17 CNY in the same period last year[24] - The net cash flow from investing activities improved by 71.91%, amounting to -¥59,924,570.81, due to a decrease in fixed asset investments[9] - The net cash flow from financing activities was -29,718,575.00 CNY, a significant decrease from 376,240,832.31 CNY in Q1 2023[24] Assets and Liabilities - Total assets at the end of Q1 2024 were ¥7,967,154,258.13, reflecting a 1.40% increase from ¥7,857,110,864.39 at the end of the previous year[5] - The company's total assets as of Q1 2024 amounted to CNY 7,967,154,258.13, compared to CNY 7,857,110,864.39 at the end of Q1 2023, reflecting a growth of 1.4%[17] - The total liabilities for Q1 2024 were CNY 4,243,595,386.44, an increase from CNY 4,096,700,919.66 in Q1 2023, indicating a rise of 3.6%[17] Shareholder Information - As of March 31, 2024, the company repurchased a total of 7,350,600 shares, accounting for 1.56% of the total shares outstanding[12] - The largest shareholder, Henan Zhengshang Development Group Co., Ltd., holds 18.60% of the shares, totaling 87,497,800 shares[11] - The second-largest shareholder, Hangzhou Yongyin Investment Partnership, holds 14.88% of the shares, totaling 70,000,000 shares[11] - The company plans to use its own funds to repurchase shares for future employee stock ownership plans, with a total repurchase fund not less than RMB 50 million and not exceeding RMB 100 million[13] - The total number of common stock shareholders at the end of the reporting period was 16,074[11] Research and Development - Research and development expenses decreased by 28.99% to ¥19,944,267.05, attributed to a reduction in R&D projects[9] - Research and development expenses for Q1 2024 were CNY 19,944,267.05, down from CNY 28,087,373.72 in Q1 2023, a decrease of 29.1%[20] Other Financial Metrics - The company received government subsidies amounting to ¥18,186,742.36, contributing to an increase in other income by 78.58%[6][9] - The company reported a decrease in cash and cash equivalents from RMB 702,996,140.16 at the beginning of the period to RMB 602,650,252.53 at the end of the period[15] - Cash and cash equivalents at the end of the period were 469,107,427.95 CNY, compared to 310,729,577.38 CNY at the end of Q1 2023[24] - The company received 24,812,232.28 CNY in tax refunds, an increase from 19,220,086.68 CNY in the previous year[24] - The total cash inflow from operating activities was 2,325,802,338.15 CNY, down from 2,869,846,047.96 CNY year-over-year[24]

2024 年 04 月 23 日 公司研究 评级：买入(维持) 研究所： 证券分析师： 李永磊 S0350521080004 liyl03@ghzq.com.cn 证券分析师： 董伯骏 S0350521080009 dongbj@ghzq.com.cn 联系人 ： 仲逸涵 S0350123070022 zhongyh@ghzq.com.cn [Table_Title] 2023 年实现扭亏为盈，2024Q1 量价齐升景气 延续 最近一年走势 2024 年 4 月 19 日，赞宇科技发布 2023 年年度报告及一季度业绩预 告：2023 年实现营业收入 96.12 亿元，同比降低 14.5%；实现归母净利 润 0.88 亿元，扭亏为盈，上年为-0.7 亿元；实现扣非归母净利润 0.37 亿元，同比上升 145.0%；销售毛利率 6.2%，同比上升 1.1 个 pct，销售 净利率 0.5%，同比上升 1.7 个 pct；经营活动现金流净额为 5.43 亿元。 2023Q4 单季度，公司实现营业收入 23.52 亿元，同比+31.4%，环 比-3.3%；实现归母净利润为-0.27 亿元，同比-81.3%，环比-1 ...